These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9623246)

  • 1. [Virological evaluation of the treatment of HIV-infected patients with (combinations of) antiretroviral agents in the Academic Medical Center of Amsterdam].
    Monteny M; Kroes AC; Groeneveld PH; Kroon FP
    Ned Tijdschr Geneeskd; 1998 May; 142(20):1169-70. PubMed ID: 9623246
    [No Abstract]   [Full Text] [Related]  

  • 2. [HIV-1 therapy in the Netherlands; virological and immunological response to antiretroviral therapy].
    Jambroes M; Weverling GJ; Reiss P; Danner SA; Jurriaans S; ten Veen JH; van der Ende ME; Schutten M; Schneider MM; Schuurman R; Mulder JW; Kroes AC; Lange JM; de Wolf F;
    Ned Tijdschr Geneeskd; 2001 Aug; 145(33):1591-7. PubMed ID: 11534377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-HIV-1 intermittent drug intensification in HIV-1-infected patients naive for antiretrovirals.
    Rusconi S; Argenteri B; Galli M; d'Arminio-Monforte A; Moroni M
    Antivir Ther; 1999; 4(3):183-4. PubMed ID: 12731759
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term virological outcome in patients infected with multi-nucleoside analogue-resistant HIV-1.
    Clevenbergh P; Kirstetter M; Liotier JY; Dupon M; Philibert P; Jacomet C; Cua E; Montagne N; Schmit JC; Dellamonica P
    Antivir Ther; 2002 Dec; 7(4):305-8. PubMed ID: 12553486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of viral load blips, drug boosting, and therapeutic holidays in HIV patient management.
    Bean P
    Am Clin Lab; 2001 Sep; 20(8):11-3. PubMed ID: 11586932
    [No Abstract]   [Full Text] [Related]  

  • 6. Reductions in viral load and increases in T lymphocyte numbers in treatment-naive patients with advanced HIV-1 infection treated with ritonavir, zidovudine and zalcitabine triple therapy.
    Mathez D; Bagnarelli P; Gorin I; Katlama C; Pialoux G; Saimot G; Tubiana P; De Truchis P; Chauvin JP; Mills R; Rode R; Clementi M; Leibowitch J
    Antivir Ther; 1997 Jul; 2(3):175-83. PubMed ID: 11322272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New AIDS study confirms: triple combination therapy with the protease inhibitor indinavir lowers the risk of mortality by 50%].
    Praxis (Bern 1994); 1997 May; 86(20):860. PubMed ID: 9312815
    [No Abstract]   [Full Text] [Related]  

  • 8. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
    Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to antiretroviral therapy and outcomes in HIV-infected patients enrolled in an induction/maintenance randomized trial.
    Flandre P; Peytavin G; Meiffredy V; Saidi Y; Descamps D; Delagnes M; Brun-Vézinet F; Raffi F;
    Antivir Ther; 2002 Jun; 7(2):113-21. PubMed ID: 12212923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug combination shows benefits for AIDS patients with history of taking AZT.
    AIDS Patient Care STDS; 1996 Jun; 10(3):185-6. PubMed ID: 11361628
    [No Abstract]   [Full Text] [Related]  

  • 11. Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens.
    Hogg RS; Yip B; Kully C; Craib KJ; O'Shaughnessy MV; Schechter MT; Montaner JS
    CMAJ; 1999 Mar; 160(5):659-65. PubMed ID: 10102000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [HIV infection and AIDS].
    Kimura T; Matsushita S
    Ryoikibetsu Shokogun Shirizu; 2000; (32):377-9. PubMed ID: 11212750
    [No Abstract]   [Full Text] [Related]  

  • 13. Predictors of tonsillar tissue HIV-1 viral burden at baseline and after 1 year of antiretroviral therapy.
    Navarrete P; Morente V; García F; Alós L; Arnedo M; Plana M; Gil C; Caballero M; Miró JM; Martínez E; Fumero E; Castro P; Blanco JL; Mallolas J; Blanch JL; Cruceta A; Mestre G; Pumarola T; Gallart T; Gatell JM
    Antivir Ther; 2003 Dec; 8(6):635-7. PubMed ID: 14760898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early antiretroviral therapy: rationale, protease inhibitor-sparing regimens and once daily dosing.
    Gatell JM
    Antivir Ther; 1998; 3 Suppl 4():49-53. PubMed ID: 10723510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognosis depends on viral load. AIDS: frequently too much time is wasted].
    Fortschr Med; 1997 Jun; 115(16):14. PubMed ID: 9280745
    [No Abstract]   [Full Text] [Related]  

  • 16. UCLA researcher demonstrates new ways to assess drug treatment in HIV-infected patients.
    AIDS Patient Care STDS; 1996 Jun; 10(3):189-90. PubMed ID: 11361638
    [No Abstract]   [Full Text] [Related]  

  • 17. Adherence to highly active antiretroviral therapy.
    Zuger A
    AIDS Clin Care; 1997 Nov; 9(11):86-7. PubMed ID: 11364775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low plasma concentrations of indinavir are related to virological treatment failure in HIV-1-infected patients on indinavir-containing triple therapy.
    Burger DM; Hoetelmans RM; Hugen PW; Mulder JW; Meenhorst PL; Koopmans PP; Brinkman K; Keuter M; Dolmans W; Hekster YA
    Antivir Ther; 1998; 3(4):215-20. PubMed ID: 10682141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ritonavir and saquinavir combination: 12-week data at ICAAC.
    James JS
    AIDS Treat News; 1996 Oct; (No 256):3. PubMed ID: 11363880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term anti-HIV activity of the combination of didanosine and hydroxyurea.
    Clotet B; Ruiz L; Cabrera C; Ibáñez A; Cañadas MP; Sirera G; Romeu J; Vila J
    Antivir Ther; 1996 Aug; 1(3):189-93. PubMed ID: 11322253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.